This content is not available in your region

CMA finds Alliance, Advanz carved up market for antibiotic

Access to the comments Comments
By Reuters
Text size Aa Aa

(Reuters) – The UK Competition and Markets Authority (CMA) on Thursday said it had found provisionally that sellers of antibiotic Nitrofurantoin broke competition law by “arranging to carve up the market between them”.

The watchdog said from 2014 to at least October 2017, two suppliers, Advanz Pharma Corp <ADVZ.TO> and Morningside, and a wholesaler, Alliance Healthcare <ALLA.SI>, entered into arrangements under which Alliance would buy equal volumes of the drug from each of the suppliers so that they would not compete.

(Reporting by Justin George Varghese in Bengaluru; editing by Patrick Graham)

Euronews provides articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.